Latent Labs is a computational biology company founded in 2023, headquartered in London and San Francisco, that builds AI foundation models designed to capture the fundamental principles of molecular design. Its work aims to make biology programmable for partners in the biotechnology and pharmaceutical sectors. The company has raised $50 million in funding to pursue this objective.
The company's technical work spans generative AI, computational biology, protein design, and foundation models for molecular design. Its product line includes Latent-X and Latent-X2, both frontier AI foundation models for molecular design and protein binding that deliver state-of-the-art results in protein binding performance.
The founding team comprises researchers and engineers drawn from DeepMind, Microsoft, Google, Stability AI, Exscientia, Mammoth Bio, Altos Labs, and Zymergen. Latent Labs positions itself as assembling world-class talent at the intersection of artificial intelligence and biology to tackle one of the harder problems in modern drug discovery and molecular engineering.
